These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2441093)

  • 1. [O-serotypes, biochemical properties and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens].
    Marumo K; Aoki Y; Takeuchi T
    Rinsho Byori; 1987 May; 35(5):555-60. PubMed ID: 2441093
    [No Abstract]   [Full Text] [Related]  

  • 2. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
    Marumo K; Takeuchi T; Aoki Y
    Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
    Marumo K; Nakamura Y; Fukuda S
    Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
    Marumo K; Nakamura Y; Sakurai C
    Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotyping of Serratia marcescens: confirmation of five recently described new O-antigens and characterization of an additional O-antigen.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):307-11. PubMed ID: 7029967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
    Marumo K; Nakamura Y; Togashi M
    Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [O-serotypes, biotypes, and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens: 3rd report].
    Marumo K; Nagaki T; Nakamura Y
    Rinsho Byori; 1992 Dec; 40(12):1312-8. PubMed ID: 1307637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Serratia marcescens isolates from subgingival biofilm, extraoral infections and environment by prodigiosin production, serotyping, and genotyping.
    Barbosa FC; Irino K; Carbonell GV; Mayer MP
    Oral Microbiol Immunol; 2006 Feb; 21(1):53-60. PubMed ID: 16390342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1105-13. PubMed ID: 9856647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serratia marcescens: biochemical characteristics, antimicrobial sensitivity and clinical significance.
    Puthucheary SD; Ngeow YF
    Malays J Pathol; 1981 Aug; 4():35-41. PubMed ID: 6764658
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on Serratia marcesceus; biochemical behavior of marcesceus strains and sensitivity to antimicrobials].
    Domínguez Rojas V; Ales JM; Soriano García F
    Rev Clin Esp; 1977 May; 145(4):265-9. PubMed ID: 325609
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmid prevalence in antibiotic resistant Serratia marcescens.
    Llanes C; Michel-Briand Y; Bailly C; Grimont F
    J Chemother; 1989 Jul; 1(4 Suppl):311-2. PubMed ID: 16312416
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on serotyping, phage typing and drug resistance of Serratia marcescens isolated from clinical specimens (author's transl)].
    Morishita H
    Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1313-27. PubMed ID: 7007698
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide recovery restores susceptibility levels towards beta-lactams in Serratia marcescens.
    Palomar J; Puig M; Montilla R; Lorén JG; Viñas M
    Microbios; 1995; 82(330):21-6. PubMed ID: 7540714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotyping of Serratia marcescens: detection of two new O-antigens (O25 and O26).
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):495-9. PubMed ID: 1721816
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotyping of Serratia marcescens: identification of a new O-antigen (O24).
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):485-8. PubMed ID: 2413654
    [No Abstract]   [Full Text] [Related]  

  • 18. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 19. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
    Cardos SF; Florman AL; Simberkoff MS; Lanier L
    Am J Med Sci; 1973 Dec; 266(6):447-52. PubMed ID: 4590096
    [No Abstract]   [Full Text] [Related]  

  • 20. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.